liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial in BLOOD, vol 114, issue 22, pp 221-221
Sahlgrens University Hospital.
Rigshosp, Copenhagen, Denmark .
St Olavs Hospital.
Lund University Hospital.
Show others and affiliations
2009 (English)In: BLOOD, American Society of Hematology , 2009, Vol. 114, no 22, 221-221 p.Conference paper, Published paper (Refereed)
Abstract [en]

n/a

Place, publisher, year, edition, pages
American Society of Hematology , 2009. Vol. 114, no 22, 221-221 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-57175ISI: 000272725800531OAI: oai:DiVA.org:liu-57175DiVA: diva2:323539
Available from: 2010-06-11 Created: 2010-06-11 Last updated: 2010-06-11

Open Access in DiVA

No full text

Authority records BETA

Ahlberg, Lucia

Search in DiVA

By author/editor
Ahlberg, Lucia
By organisation
Oncology Faculty of Health SciencesDepartment of Haematology UHL
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 89 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf